FDA Drafts Guidance on Replacing Reagents for IVD Devices Post author:Sam Post published:February 15, 2018 Post category:The GMP Letter The FDA issued draft guidance to provide updates on in vitro diagnostics’ replacement reagents. Source: The GMP Letter You Might Also Like EC Releases Guidelines on Benefit-Risk Analysis for Phthalates October 14, 2019 Cyber Risk Prompts Abbott Recall of 465K Pacemakers October 9, 2017 Expert: ISO 13485 Could Cause Confusion With FDA’s Quality System Regulation March 3, 2016